In adult B-ALL cases, PAX5 P80R has been associated with favorable outcomes [34], while it has been shown to contribute to poorer outcomes in childhood cases [31]. This evidence concerns the gene PAX5 and precursor B-cell acute lymphoblastic leukemia.